International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia
Clinical trial NCT03705507 · TERMINATED
Trial details
- NCT number
- NCT03705507
- Sponsor
- University of Birmingham
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-18
- Primary completion
- 2023-05-03
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.